TheraRadar
Clinical-Stage Companies / Bharat Biotech International Limited

Bharat Biotech International Limited

Pre-Approval PRO BETA
14
Total Trials
7
Phase 3
5
Phase 2
3
Recruiting
165
Score

Pipeline by Phase

Phase 3
7
Phase 2
5
Phase 1
5

Therapeutic Focus

Rotavirus Gastroenteritis Tuberculosis (TB) Tuberculosis Rotavirus Infection of Children Corona Virus Infection

Clinical Trials (14)

NCT06200844 Phase 3 ACTIVE NOT RECRUITING

The Efficacy of Oral Rotavirus Vaccine 116E (ROTAVAC 5D) in Chilean Infants

Started: 7/7/2023

NCT05567471 Phase 3 COMPLETED

Phase 3 Study to Evaluate Immunogenicity and Safety of BBV154 Booster Dose

Started: 2/26/2022

NCT04819412 Phase 3 COMPLETED

To Determine the Safety and Efficacy of Liquid ROTAVAC 5C Vaccine Against Childhood Diarrhea Caused by Rotavirus

Started: 3/20/2015

NCT01305226 Phase 3 COMPLETED

A Trial Using Double-Bolus THR-100 Versus Streptokinase

Started: 10/1/2010

NCT04596696 Phase 3 COMPLETED

Evaluate Immunogenicity, Safety, and Reactogenicity of Rotavac in Healthy Infants in Vietnam

Started: 12/20/2017

NCT07555392 Phase 2 RECRUITING

A Seamless Phase II/III, Observer-blind, to Evaluate Immunogenicity and Safety of Chikungunya Virus Vaccine in Healthy Subjects 12-65Years of Age.

Started: 4/20/2026

NCT06997367 Phase 2 ACTIVE NOT RECRUITING

Safety and Immunogenicity of a Mycobacterium Tuberculosis Vaccine MTBVAC in Healthy Indian Adults and Adolescents (BBV169/2024)

Started: 3/27/2025

NCT05639998 Phase 2 COMPLETED

BBV152/BBV154 Heterologus Prime-Boost Study

Started: 9/1/2021

NCT04918797 Phase 2 COMPLETED

COVAXIN in a Pediatric Cohort

Started: 5/26/2021

NCT06438978 Phase 1 COMPLETED

Tuberculosis Vaccine in Healthy Indian Adults

Started: 1/19/2024

NCT04471519 Phase 1 COMPLETED

Whole-Virion Inactivated SARS-CoV-2 Vaccine (BBV152) for COVID-19 in Healthy Volunteers

Started: 7/15/2020

NCT04751682 Phase 1 COMPLETED

Safety and Immunogenicity of an Intranasal SARS-CoV-2 Vaccine (BBV154) for COVID-19

Started: 3/1/2021

NCT04603131 Phase 1 COMPLETED

Clinical Trial to Evaluate the Immunogenicity of Chikungunya Vaccine

Started: 4/17/2017

NCT04478656 Phase 1 COMPLETED

Safety and Immunogenicity of BBV121

Started: 6/3/2017

Drug Candidates

MTBVAC BCG Sii Tuberculosis Vaccine ROTAVAC 5D COVAXIN(BBV152) BBV154 Intranasal Vaccine Intramuscular vaccine COVAXIN Covishield BBV152A - Phase I BBV152B - Phase I
Activity Status: Active
Last Trial Started: 4/20/2026
Last Trial Ended: 7/27/2024
Trials (12 months): 1
Completed Trials: 11
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.